Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus Mesa Laboratories Inc MLAB Q1 2026 Earnings Stellar EPS Surprise of 130 Drives Optimism Amidst Quiet Revenue Period NYT Q1 2026 Earnings EPS Surges Past Estimates with 2746 Surprise SCSC Q1 2026 Earnings EPS Slightly Misses Estimates Sentiment Remains Cautiously Optimistic WNC Q1 2026 Earnings EPS Falls Sharply Below Expectations as Operational Headwinds Persist Yatsen Holding YSG Rebounds 386 as Cosmetics Stock Tests Key Resistance SherwinWilliams SHW Holds Steady Near 310 as Housing Market Uncertainties Persist Kiniksa Pharmaceuticals Holds Steady Near 54 as Stock Tests Key Resistance Levels Innospec Inc IOSP Climbs 3 as Stock Approaches Key Resistance Level PLXS Q1 2026 Earnings EPS Beats Estimates Stock Rises GAIA Q1 2026 Earnings Loss Narrowly Misses Estimates Shares Rise on Strategic Progress Eton Pharmaceuticals Q1 2026 Earnings EPS Miss Triggers Stock Decline OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline KYN Q4 2015 Earnings Slight EPS Miss Amid Energy Infrastructure Challenges ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Caps a Quarter of Pipeline Progress CVR Energy Q1 2026 Earnings Substantial EPS Miss Amid Challenging Refining Environment